Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 133
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
Opt Express ; 30(4): 4978-4987, 2022 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-35209469

RESUMEN

Due to the high intensity and MHz repetition rate of photon pulses generated by the European X-ray Free-Electron Laser, the heat load on silicon crystal monochromators can become large and prevent ideal transmission in Bragg diffraction geometry due to crystal deformation. Here, we present experimental data illustrating how heat load affects the performance of a cryogenically cooled monochromator under such conditions. The measurements are in good agreement with a depth-uniform model of X-ray dynamical diffraction taking beam absorption and heat deformation of the crystals into account.

2.
J Investig Allergol Clin Immunol ; 31(4): 282-291, 2021 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-33030434

RESUMEN

BACKGROUND AND OBJECTIVES: According to current guidelines, oral antihistamines are the first-line treatment for chronic spontaneous urticaria (CSU). Up-dosing antihistamines to 4-fold the licensed dose is recommended if control is not achieved. Such indications are based mainly on expert opinion. Objectives: To critically review and analyze clinical evidence on the efficacy and safety of higher-than-licensed dosage of second-generation oral antihistamines in the treatment of CSU. MATERIAL AND METHODS: A systematic literature review was performed following a sensitive search strategy. All articles published in PubMed, EMBASE, and the Cochrane Library between 1961 and October 2018 were examined. Publications with CSU patients prescribed secondgeneration antihistamines in monotherapy compared with placebo, licensed dosages, and/or higher dosages were included. Articles were evaluated by peer reviewers. Quality was evaluated using the Jadad and Oxford scores. RESULTS: We identified 337 articles, of which 14 were included in the final evaluation (fexofenadine, 6; cetirizine, 2; levocetirizine and desloratadine, 1; levocetirizine, 1; rupatadine, 2; ebastine, 1; and bilastine, 1). Only 5 studies were placebo-controlled. The number of patients included ranged from 20 to 439. The observation lapse was ≤16 weeks. High fexofenadine doses produced a significant dosedependent response and controlled urticaria in most patients. Cetirizine, levocetirizine, rupatadine, and bilastine were more effective in up-dosing. The most frequent adverse events were headache and drowsiness. CONCLUSION: The low quality and heterogeneity of the articles reviewed made it impossible to reach robust conclusions and reveal the need for large-scale randomized clinical trials.


Asunto(s)
Antialérgicos/uso terapéutico , Urticaria Crónica/tratamiento farmacológico , Antagonistas de los Receptores Histamínicos H1 no Sedantes/uso terapéutico , Administración Oral , Animales , Ensayos Clínicos como Asunto , Cálculo de Dosificación de Drogas , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Humanos , Resultado del Tratamiento
3.
Allergy ; 73(3): 728-732, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29052246

RESUMEN

Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE-mediated gastrointestinal food hypersensitivity usually due to cow's milk or soy. Recent researches show that fish is 1 of the most important triggers of FPIES in the Mediterranean countries. Due to the risk of multiple-food FPIES, avoiding foods in the same category or that often occur together may be reasonable. The aim of this study was to evaluate the evolution and follow-up of FPIES related to fish over a period of 20 years. We describe the clinical features of our population, discuss different approaches to oral food challenges, and analyze the possibility of introducing the culprit fish or other nonrelated fish to avoid unnecessary restricted diets.


Asunto(s)
Enterocolitis/inmunología , Peces , Hipersensibilidad a los Alimentos/inmunología , Animales , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Estudios Retrospectivos
4.
J Intern Med ; 276(4): 404-12, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24815605

RESUMEN

OBJECTIVE: The impact of endogenous immunoglobulin isotypes on the prognosis of patients with severe sepsis has not been sufficiently explored. The aim of this study was to evaluate the association between immunoglobulin levels in plasma and survival in patients with this condition. DESIGN AND PATIENTS: A prospective multicentre cohort study was conducted. A total of 172 adult patients admitted to the intensive care unit (ICU) with severe sepsis or septic shock were recruited. Patients were classified based on deciles of immunoglobulin concentrations at diagnosis of sepsis. Categorical variables were created and tested for their association with survival during hospitalization in the ICU. RESULTS: Overall, 42 patients died in the ICU during the study. Kaplan-Meier analysis showed that immunoglobulin concentrations below 300 mg dL(-1) for IgG1, 35 mg dL(-1) for IgM and 150 mg dL(-1) for IgA were associated with shorter survival times. Multivariate regression analysis showed that IgG1 < 300 mg dL(-1) was a risk factor for mortality [odds ratio (OR) 2.50, 95% confidence interval (CI) 1.04-6.03; P = 0.042]. The combined presence of IgG1, IgM and IgA levels below the described thresholds had a synergistic impact on mortality risk (OR 5.27, 95% CI 1.41-19.69; P = 0.013). A similar effect was observed for combined low levels of IgG1 and IgA (OR 4.10, 95% CI 1.28-13.12; P = 0.018) and also of IgG1 and IgM (OR 3.10. 95% CI 1.13-8.49; P = 0.028). CONCLUSIONS: The combined presence of low levels of the endogenous immunoglobulins IgG1, IgM and IgA in plasma is associated with reduced survival in patients with severe sepsis or septic shock. Assessment of the concentrations of these immunoglobulins could improve the results of treatment with exogenous immunoglobulins in patients with sepsis.


Asunto(s)
Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Sepsis/inmunología , Sepsis/mortalidad , Anciano , Femenino , Humanos , Huésped Inmunocomprometido , Unidades de Cuidados Intensivos , Estimación de Kaplan-Meier , Masculino , Pronóstico , Estudios Prospectivos , Análisis de Regresión , Choque Séptico/inmunología , Choque Séptico/mortalidad
7.
Rev Neurol ; 78(1): 17-25, 2024 Jan 01.
Artículo en Español, Inglés | MEDLINE | ID: mdl-38112653

RESUMEN

INTRODUCTION: Huntington´s disease (HD) is a rare neurodegenerative disorder. Reliable information about nutritional status, especially body composition from individuals with HD is critical for clinical care and research. The ease of application and portability of multiple frequencies bioelectrical impedance analysis (mfBIA) make it an attractive tool for measuring body composition, but its accuracy in HD is unknown. AIM: To evaluate the accuracy of mfBIA vs. Dual X-ray absorptiometry (DEXA) in HD. PATIENTS AND METHODS: Cross-sectional, observational, and single-center study. HD severity was measured using motor subscale of the unified Huntington´s disease rating scale (m-UHDRS) and the total functional capacity (TFC). Body composition was measured in terms of fat-free mass (FFM), fat mass (FM), fat-free mass index (FFMI), and fat mass index (FMI). Using Bland-Altman plots, we analyzed reliability between DEXA and mfBIA using the Intraclass Correlation Coefficient with 95% confidence intervals (CI) and bias estimates for all. RESULTS: We included 16 patients with HD, 7 men, and 9 women, median age of 58.5 (32;68) years, TFC: 10 (3;13), and m-UHDRS: 31 (7;85). The reliability between mfBIA and DEXA were high for FFMI in men: 0.88 (95% CI 0.17-0.98), and women: 0.90 (95% CI 0.61- 0.98); for FMI, men: 0.97 (95% CI 0.83-0.99), and women: 0.91 (95% CI 0.68-0.98). Compared to DEXA, mfBIA slightly overestimated FFM, FM, FMI and FFMI in men and underestimated FFMI in women. CONCLUSIONS: mfBIA is an easy-to-use, safe, non-invasive, accurate method for measuring body composition and nutritional status in patients with mild-moderate HD.


TITLE: Cómo estimar la composición corporal en la enfermedad de Huntington. Estudio transversal y observacional con bioimpedancia de múltiples frecuencias.Introducción. La enfermedad de Huntington (EH) es un trastorno raro neurodegenerativo. La información fiable del estado nutricional, especialmente de la composición corporal, es crítica en clínica y en investigación. La facilidad de aplicación y portabilidad del análisis de la bioimpedancia de múltiples frecuencias (mfBIA) la convierten en una herramienta atractiva para medirla, pero se desconoce su precisión en la EH. Objetivo. Evaluar la precisión del mfBIA frente a la absorciometría dual de rayos X (DEXA) en la EH. Pacientes y métodos. Estudio transversal, observacional y unicéntrico. La EH se midió con la subescala motora de la escala unificada de valoración de la EH y con la capacidad funcional total. La composición corporal se valoró según la masa libre de grasa (MLG), la masa grasa (MG), el índice de masa libre de grasa (IMLG) y el índice de masa grasa (IMG). Se utilizó el coeficiente de correlación intraclase con intervalos de confianza al 95% y estimaciones de sesgo mediante gráficos de Bland-Altman. Resultados. Se incluyó a 16 pacientes, siete hombres y nueve mujeres, con edad media de 58,5 (32-68) años, capacidad funcional total de 10 (3-13) y escala unificada de valoración de la EH de 31 (7-85). La fiabilidad era alta entre el mfBIA y la DEXA para el IMLG en hombres, 0,88 (intervalo de confianza al 95%: 0,17-0,98), y mujeres, 0,9 (intervalo de confianza al 95%: 0,61-0,98); y para el IMG en hombres, 0,97 (intervalo de confianza al 95%: 0,83-0,99), y mujeres, 0,91 (intervalo de confianza al 95%: 0,68-0,98). El mfBIA sobreestimó ligeramente la MLG, la MG, el IMG y el IMLG en los hombres, pero subestimó el IMLG en las mujeres. Conclusiones. El mfBIA es un método fácil de usar, seguro, no invasivo y preciso para medir la composición corporal y el estado nutricional en pacientes con EH leve-moderada.


Asunto(s)
Enfermedad de Huntington , Anciano , Femenino , Humanos , Masculino , Absorciometría de Fotón/métodos , Composición Corporal , Índice de Masa Corporal , Estudios Transversales , Impedancia Eléctrica , Enfermedad de Huntington/diagnóstico , Reproducibilidad de los Resultados , Adulto , Persona de Mediana Edad
8.
J Phys Chem Lett ; 14(5): 1246-1252, 2023 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-36718641

RESUMEN

Hydrogen molecules dissociate on clean W(110) surfaces. This reaction is progressively inhibited as the tungsten surface is precovered with oxygen. We use density functional theory and ab initio molecular dynamics to rationalize, at the atomic scale, the influence of the adsorbed O atoms on the H2 dissociation process. The reaction probability is calculated for kinetic energies below 300 meV and different O nominal coverages. We show that the adsorbed O atoms act as repulsive centers that modulate the dynamics of the impinging H2 molecules by closing dissociation pathways. In agreement with existing experimental information, H2 dissociation is absent for an O coverage of half a monolayer. The results show that the influence of O adsorbates on the dissociation dynamics on W(110) goes much beyond the blocking of possible H adsorption sites. Adsorbed O atoms create a sort of chemical shield at the surface that prevents further approach and dissociation of the H2 molecules.

9.
Artículo en Inglés | MEDLINE | ID: mdl-36878314

RESUMEN

The objective of this guide is to provide to nuclear medicine physicians a tool based on scientific evidence and prepared by consensus of experts, to perform the 18F-DCFPyL PET/CT procedure with safely and efficiently for patients with prostate cancer who present PSMA overexpression. For them, some recommendations will be established for 18F-DCFPyL PET/CT examination: reconstruction parameters, presentation of the images and their interpretation. The possible false positives of the procedure will be analysed, how to interpret them and how to avoid them. Finally, all exploration should lead to the preparation of a report that answers the clinician's question. For this, it is recommended to prepare a structured report that includes the PROMISE criteria as well as the classification of the findings according to PSMA-RADS parameters.


Asunto(s)
Tomografía Computarizada por Tomografía de Emisión de Positrones , Neoplasias de la Próstata , Masculino , Humanos , Tomografía Computarizada por Tomografía de Emisión de Positrones/métodos , Lisina , Urea , Neoplasias de la Próstata/diagnóstico por imagen
10.
Artículo en Inglés | MEDLINE | ID: mdl-34454892

RESUMEN

OBJECTIVE: To determine the therapeutic effectiveness and safety of transarterial radioembolization (TARE) with Yttrium-90 in patients with colorectal cancer (CRC) liver metastases and to evaluate the prognostic value of different biomarkers. MATERIAL AND METHODS: This prospective longitudinal study enrolled consecutive patients with CRC liver metastases treated with TARE between November 2015 and june 2020. The therapeutic response at three and six months (RECIST1.1 criteria) and the relationship of biomarkers with therapeutic response, by calculating objective tumor response rates (ORR) and disease control (DCR), and overall survival (OS) and progression-free (PFS). RESULTS: Thirty TAREs were performed in 23 patients (mean age, 61.61 ±â€¯9.13 years; 56.5% male). At three months, the objective response rate (ORR) was 16.7% and the disease control rate (DCR) 53.3%. At six months, the disease progressed in 80%. The ORR and DCR were significantly associated with age at diagnosis (P = 0.047), previous bevacizumab treatment (P = 0.008), pre-TARE haemoglobin (P = 0.008), NLR (P = 0.040), pre-TARE albumin (P = 0.012), pre-TARE ALT (P = 0.023) and tumour-absorbed dose > 115 Gy (P = 0.033). Median overall survival (OS) was 12 months (95% CI, 4.75-19.25 months) and median progression-free survival (PFS) 3 months (95% CI, 2.41-3.59). OS was significantly associated with primary tumour resection (P = 0.019), KRAS mutation (HR: 5.15; P = 0.024), pre-TARE haemoglobin (HR: 0.50; p = 0.009), pre-TARE NLR (HR: 1.65; P = 0.005) and PLR (HR: 1.01; P = 0.042). CONCLUSION: TARE prognosis and therapeutic response were predicted by different biomarkers, ranging from biochemical parameters to tumour dosimetrics.


Asunto(s)
Neoplasias del Colon , Neoplasias Hepáticas , Anciano , Biomarcadores , Femenino , Humanos , Neoplasias Hepáticas/secundario , Estudios Longitudinales , Masculino , Microesferas , Persona de Mediana Edad , Estudios Prospectivos , Radiofármacos/uso terapéutico , Estudios Retrospectivos , Radioisótopos de Itrio
11.
Artículo en Inglés, Español | MEDLINE | ID: mdl-34294586

RESUMEN

OBJETIVE: To determine the therapeutic effectiveness and safety of transarterial radioembolization (TARE) with Yttrium-90 in patients with colorectal cancer (CRC) liver metastases and to evaluate the prognostic value of different biomarkers. MATERIAL AND METHODS: This prospective longitudinal study enrolled consecutive patients with CRC liver metastases treated with TARE between November 2015 and june 2020. The therapeutic response at three and six months (RECIST1.1 criteria) and the relationship of biomarkers with therapeutic response, by calculating objective tumor response rates (ORR) and disease control (DCR), and overall survival (OS) and progression-free (PFS). RESULTS: Thirty TAREs were performed in 23 patients (mean age, 61,61±9,13 years; 56,5% male). At three months, the objective response rate (ORR) was 16,7% and the disease control rate (DCR) 53,3%. At six months, the disease progressed in 80%. The ORR and DCR were significantly associated with age at diagnosis (P=.047), previous bevacizumab treatment (P=.008), pre-TARE haemoglobin (P=.008), NLR (P=.040), pre-TARE albumin (P=.012), pre-TARE ALT (P=.023) and tumour-absorbed dose>115Gy (P=.033). Median overall survival (OS) was 12 months (95% CI, 4.75-19.25 months) and median progression-free survival (PFS) 3 months (95% CI, 2.41-3.59). OS was significantly associated with primary tumour resection (P=.019), KRAS mutation (HR: 5.15; P=.024), pre-TARE haemoglobin (HR: .50; p=.009), pre-TARE NLR (HR: 1.65; P=.005) and PLR (HR: 1.01; P=.042). CONCLUSION: TARE prognosis and therapeutic response were predicted by different biomarkers, ranging from biochemical parameters to tumour dosimetrics.

12.
Rev Esp Med Nucl ; 29(5): 258-62, 2010.
Artículo en Español | MEDLINE | ID: mdl-20462672

RESUMEN

Perivascular epithelioid tumors (PEComas) are a rare group of mesenchymal neoplasms with an unpredictable natural history and uncertain malignant potential. Uterine involvement and their association with tuberous sclerosis are typical for these tumors. We present a case of a 40-year old patient who was incidentally diagnosed of a uterine PEComa and serial studies of PET-CT with FDG were performed for staging and therapeutic response assessment. FDG PET-CT proved to be a valuable tool for detecting unsuspected pulmonary metastases and defining the reassessment of the patient after chemotherapy. The findings suggest that since this is a rare tumor, which does not always have benign behaviour, PET-CT may be a useful diagnostic imaging procedure for staging and clinical monitoring of patients who suffer this type of tumors.


Asunto(s)
Neoplasias Endometriales/diagnóstico por imagen , Estrógenos , Radioisótopos de Flúor , Fluorodesoxiglucosa F18 , Neoplasias Pulmonares/secundario , Neoplasias Hormono-Dependientes/diagnóstico por imagen , Neoplasias de Células Epitelioides Perivasculares/diagnóstico por imagen , Tomografía de Emisión de Positrones , Radiofármacos , Tomografía Computarizada por Rayos X , Adulto , Angiofibroma/diagnóstico por imagen , Angiofibroma/genética , Quimioterapia Adyuvante , Terapia Combinada , Neoplasias Endometriales/patología , Neoplasias Endometriales/cirugía , Neoplasias Faciales/genética , Femenino , Humanos , Histerectomía , Hallazgos Incidentales , Neoplasias Renales/diagnóstico por imagen , Neoplasias Pulmonares/diagnóstico por imagen , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Hormono-Dependientes/tratamiento farmacológico , Neoplasias Hormono-Dependientes/secundario , Neoplasias Hormono-Dependientes/cirugía , Neoplasias Primarias Múltiples/diagnóstico por imagen , Neoplasias de Células Epitelioides Perivasculares/tratamiento farmacológico , Neoplasias de Células Epitelioides Perivasculares/secundario , Neoplasias de Células Epitelioides Perivasculares/cirugía , Esclerosis Tuberosa/diagnóstico por imagen , Esclerosis Tuberosa/genética
13.
Rev Esp Med Nucl ; 29(3): 131-4, 2010.
Artículo en Español | MEDLINE | ID: mdl-20227797

RESUMEN

The combination of positron emission tomography (PET) and computed tomography (CT) in a single device (PET/CT) offers a powerful diagnostic tool that opens up new horizons for imaging diagnosis. In order to correctly interpret PET/CT studies, knowledge of the biodistribution of 18F-fluorodeoxyglucose (FDG), the physiological variants as well as the pitfalls, including artefacts, which may be found, is necessary. We report four cases performed during the follow-up diagnostic context of an oncology study performed with 18F-FDG-PET/CT. In every case, this study showed focal uptake in the lung parenchyma in the PET study with no structural lesions being found on the CT scan. Radiotracer extravasation in three of these patients and a recent change in the injection protocol used suggest that an artefact was responsible for these discrepancies.


Asunto(s)
Artefactos , Endotelio Vascular/lesiones , Extravasación de Materiales Terapéuticos y Diagnósticos/diagnóstico por imagen , Radioisótopos de Flúor , Fluorodesoxiglucosa F18 , Inyecciones Intravenosas/efectos adversos , Neoplasias Pulmonares/secundario , Pulmón/diagnóstico por imagen , Tomografía de Emisión de Positrones , Embolia Pulmonar/diagnóstico por imagen , Radiofármacos , Adulto , Anciano , Enfermedad de Castleman/diagnóstico por imagen , Diagnóstico Diferencial , Reacciones Falso Positivas , Radioisótopos de Flúor/administración & dosificación , Radioisótopos de Flúor/farmacocinética , Fluorodesoxiglucosa F18/administración & dosificación , Fluorodesoxiglucosa F18/farmacocinética , Humanos , Inyecciones Intravenosas/instrumentación , Inyecciones Intravenosas/métodos , Pulmón/irrigación sanguínea , Neoplasias Pulmonares/diagnóstico por imagen , Metástasis Linfática , Masculino , Persona de Mediana Edad , Embolia Pulmonar/etiología , Radiofármacos/administración & dosificación , Radiofármacos/farmacocinética , Nódulo Pulmonar Solitario/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Parálisis de los Pliegues Vocales/diagnóstico por imagen
14.
Rev Esp Quimioter ; 33(6): 444-447, 2020 Dec.
Artículo en Español | MEDLINE | ID: mdl-32957746

RESUMEN

OBJECTIVE: Co-circulation of the two Influenza B lineages hinders forecast of strain to include in trivalent vaccine. Autonomous Communities such as Cantabria continue without supplying tetravalent vaccine. The aim of this study was to analyse epidemiological characteristics of influenza type B in Cantabria (2019-2020 season) as well as to establish the predominant lineage and its relation to the recommended vaccine. METHODS: Retrospective study whereby flu diagnosis and lineage analysis were determined by RT-PCR. RESULTS: All samples belonged to the Victoria lineage. Most prevalent viral co-infection was due to SARS-CoV-2. The population affected by influenza B was mainly paediatric and non-vaccinated patients more frequently required hospital admittance. CONCLUSIONS: Influenza type B has a higher incidence in the paediatric population and type A affects more the adult population. Only 28.8% of patients with Influenza B that presented with some underlying condition or risk factor were vaccinated. This shows the need to increase coverage with tetravalent vaccines in order to reduce the burden of disease associated with the Influenza B virus.


Asunto(s)
COVID-19/epidemiología , Virus de la Influenza B , Gripe Humana/epidemiología , Pandemias , SARS-CoV-2 , Adulto , COVID-19/virología , Distribución de Chi-Cuadrado , Niño , Coinfección/epidemiología , Coinfección/virología , Epidemias , Femenino , Hospitalización/estadística & datos numéricos , Humanos , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/prevención & control , Gripe Humana/virología , Masculino , Estudios Retrospectivos , Estaciones del Año , España/epidemiología , Estadísticas no Paramétricas
15.
Artículo en Inglés, Español | MEDLINE | ID: mdl-31740380

RESUMEN

Leiomyomas are benign tumors derived from smooth muscle tissue that rarely present outside the uterus. These tumors do not usually show FDG uptake. We present the case of a patient with hypertension refractory to treatment and a lesion arising from inferior vena cava, that shows intense FDG uptake in PET/CT scan, suggestive of paraganglioma, with a final histological diagnosis of leiomyoma.


Asunto(s)
Fluorodesoxiglucosa F18 , Leiomioma/diagnóstico por imagen , Paraganglioma/diagnóstico por imagen , Tomografía Computarizada por Tomografía de Emisión de Positrones , Radiofármacos , Neoplasias Vasculares/diagnóstico por imagen , Vena Cava Inferior/diagnóstico por imagen , 3-Yodobencilguanidina , Diagnóstico Diferencial , Fluorodesoxiglucosa F18/farmacocinética , Humanos , Hipertensión , Leiomioma/metabolismo , Masculino , Persona de Mediana Edad , Radiofármacos/farmacocinética , Neoplasias Vasculares/metabolismo , Vena Cava Inferior/metabolismo
16.
Appl Radiat Isot ; 165: 109247, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32692657

RESUMEN

The Granada group in BNCT research is currently performing studies on: nuclear and radiobiological data for BNCT, new boron compounds and a new design for a neutron source for BNCT and other applications, including the production of medical radioisotopes. All these activities are described in this report.


Asunto(s)
Terapia por Captura de Neutrón de Boro/métodos , Aceleradores de Partículas , Humanos , Método de Montecarlo , Neutrones
17.
Rev Esp Med Nucl ; 28(2): 74-7, 2009.
Artículo en Español | MEDLINE | ID: mdl-19406053

RESUMEN

Gallbladder cancer is the most common biliary tract neoplasm. It generally affects the elderly, who are usually clinically asymptomatic. When symptoms appear, they suggest the presence of complications locally or due to tumour progression. Late diagnosis of the disease indicates a poor prognosis for these patients. Surgery is the only treatment with curative intent, but it is only possible in the early stages. Diagnostic imaging of this type of tumour is usually performed with ultrasonography, computed tomography or magnetic resonance cholangiography. Positron emission tomography (PET) with fluorodeoxyglucose (FDG) with dedicated scanners or hybrid PET-CT scans are new diagnostic tools which could help in the pre-surgical diagnosis of these tumours. We present three cases to illustrate the usefulness of PET-FDG in the pre-surgical staging of gallbladder cancer.


Asunto(s)
Adenocarcinoma/diagnóstico por imagen , Radioisótopos de Flúor , Fluorodesoxiglucosa F18 , Neoplasias de la Vesícula Biliar/diagnóstico por imagen , Estadificación de Neoplasias/métodos , Tomografía de Emisión de Positrones , Radiofármacos , Adenocarcinoma/complicaciones , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/patología , Adenocarcinoma/cirugía , Anciano , Antineoplásicos/uso terapéutico , Neoplasias de la Mama , Colecistectomía , Colelitiasis/complicaciones , Terapia Combinada , Desoxicitidina/análogos & derivados , Desoxicitidina/uso terapéutico , Femenino , Neoplasias de la Vesícula Biliar/complicaciones , Neoplasias de la Vesícula Biliar/tratamiento farmacológico , Neoplasias de la Vesícula Biliar/patología , Neoplasias de la Vesícula Biliar/cirugía , Humanos , Hígado/diagnóstico por imagen , Hígado/patología , Invasividad Neoplásica/diagnóstico por imagen , Neoplasias Primarias Secundarias/diagnóstico por imagen , Cuidados Preoperatorios , Gemcitabina
18.
Rev Esp Med Nucl ; 28(2): 70-3, 2009.
Artículo en Español | MEDLINE | ID: mdl-19406052

RESUMEN

Desmoid tumours are uncommon benign tumours but with aggressive behaviour, resulting from the proliferation of well-differentiated fibroblasts. Clinically, they present as a painless firm soft tissue mass. They can be solitary or multiple and have potential infiltrative capacity. When planning treatment, it is important to assess the correct tumour extent to permit curative radical surgery minimizing possible local recurrence. Different imaging techniques help to characterise these tumours. At present, magnetic resonance is the tool of choice for studying these tumours. The role of nuclear medicine techniques, such as bone scintigraphy, or more recently FDG-PET, has not been defined in the evaluation of these neoplasms. We present the case of a patient with a desmoid tumour of the abdominal-chest wall and we review the related literature.


Asunto(s)
Neoplasias Abdominales/diagnóstico por imagen , Pared Abdominal/diagnóstico por imagen , Neoplasias Óseas/diagnóstico por imagen , Fibromatosis Agresiva/diagnóstico por imagen , Radioisótopos de Flúor , Fluorodesoxiglucosa F18 , Neoplasias de los Músculos/diagnóstico por imagen , Tomografía de Emisión de Positrones , Radiofármacos , Recto del Abdomen/diagnóstico por imagen , Costillas/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Pared Abdominal/patología , Adulto , Neoplasias Óseas/patología , Neoplasias Óseas/cirugía , Fibromatosis Agresiva/patología , Fibromatosis Agresiva/cirugía , Humanos , Imagen por Resonancia Magnética , Masculino , Neoplasias de los Músculos/patología , Neoplasias de los Músculos/cirugía , Invasividad Neoplásica , Recto del Abdomen/patología , Pared Torácica/diagnóstico por imagen , Pared Torácica/patología
19.
J Phys Chem Lett ; 10(24): 7629-7635, 2019 Dec 19.
Artículo en Inglés | MEDLINE | ID: mdl-31774684

RESUMEN

When elementary reactive processes occur at such low energies that only a few states of reactants and/or products are available, quantum effects strongly manifest and the standard description of the dynamics within the classical framework fails. We show here, for H2 scattering on Pd(111), that by pseudoquantizing in the spirit of Bohr the relevant final actions of the system, along with adequately treating the diffraction-mediated trapping of the incoming wave, classical simulations achieve an unprecedented agreement with state-of-the-art quantum dynamics calculations.

20.
Actas Urol Esp (Engl Ed) ; 43(2): 55-61, 2019 Mar.
Artículo en Inglés, Español | MEDLINE | ID: mdl-30082102

RESUMEN

INTRODUCTION: In castration-resistant prostate cancer (CRPC), early detection of metastases is essential for the selection of treatment, and prevention of bone complications. However detecting incipient metastases remains a challenge as the conventional radiological tests (bone scintigraphy or computerised tomography) lack sufficient sensitivity. Diagnostic imaging techniques are currently available that have greater sensitivity and specificity, but are little used due to shortfalls in the recommendations. OBJECTIVE: To create an algorithm that indicates the most suitable diagnostic imaging techniques for the different M0 CRPC patient profiles based on the scientific evidence. EVIDENCE ACQUISITION: Meetings were held with eight experts in Urology, Pathological Anatomy, Radiodiagnostics and Nuclear Medicine organised by the Andalusian Association of Urology, in which the recommendations and scientific evidence on each of the diagnostic imaging techniques were reviewed. SUMMARY OF THE EVIDENCE: We present the current recommendations for the detection of metastasis in M0 CRPC patients, the patients that would benefit from early detection, and summarise the evidence to support the use of each of the new techniques. CONCLUSIONS: Techniques such as 18F-Choline PET/CT or DWWB MRI and probably open MRI have been demonstrated to have good sensitivity and specificity for patients with low PSA (<10ng/ml). Their inclusion in routine clinical practice will help improve the early detection of metastasis in CRPC patients.


Asunto(s)
Algoritmos , Neoplasias Óseas/diagnóstico por imagen , Neoplasias Óseas/secundario , Toma de Decisiones Clínicas , Neoplasias de la Próstata Resistentes a la Castración/patología , Humanos , Imagen por Resonancia Magnética , Masculino , Tomografía Computarizada por Tomografía de Emisión de Positrones , Guías de Práctica Clínica como Asunto , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA